Public disclosures

Smart Money

Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.

Advertisement
More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSourceFollow
SHUGAR DANIEL S

Chief Executive Officer · Director · Nextpower Inc.

NXT

Nextpower Inc.

Exercise or conversion
Filing details

SEC transaction code M

Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 119268 · The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2026.

2026-11-182026-11-20

34,253 shares/units

SEC 4Follow
SHUGAR DANIEL S

Chief Executive Officer · Director · Nextpower Inc.

NXT

Nextpower Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 871131 · SEC code covers open-market or private transactions · The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2026. · The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $80.00 to $80.38, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares sold at each separate price within such ranges.

2026-11-192026-11-20

≈ $36,046.22

450 shares/units

SEC 4Follow
SHUGAR DANIEL S

Chief Executive Officer · Director · Nextpower Inc.

NXT

Nextpower Inc.

Exercise or conversion
Filing details

SEC transaction code M

Common Stock · Direct ownership · Reported balance after transaction: 871581 · The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2026.

2026-11-192026-11-20

450 shares/units

SEC 4Follow
SHUGAR DANIEL S

Chief Executive Officer · Director · Nextpower Inc.

NXT

Nextpower Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 871131 · SEC code covers open-market or private transactions · The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2026. · The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $81.059 to $81.357, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares sold at each separate price within such ranges.

2026-11-182026-11-20

≈ $123,391.26

1,519 shares/units

SEC 4Follow
SHUGAR DANIEL S

Chief Executive Officer · Director · Nextpower Inc.

NXT

Nextpower Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 872650 · SEC code covers open-market or private transactions · The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2026. · The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $80.000 to $80.953, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares sold at each separate price within such ranges.

2026-11-182026-11-20

≈ $2,630,841.40

32,734 shares/units

SEC 4Follow
SHUGAR DANIEL S

Chief Executive Officer · Director · Nextpower Inc.

NXT

Nextpower Inc.

Exercise or conversion
Filing details

SEC transaction code M

Common Stock · Direct ownership · Reported balance after transaction: 905384 · The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2026.

2026-11-182026-11-20

34,253 shares/units

SEC 4Follow
Kumar Neil

Chief Executive Officer · Director · BridgeBio Pharma, Inc.

BBIO

BridgeBio Pharma, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Indirect ownership · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. · Reported balance after transaction: 475686 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026. · Represents the weighted average sale price of the shares sold from $79.04 to $79.73 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. · The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

2026-11-192026-11-20

≈ $118,939.50

1,500 shares/units

SEC 4Follow
Kumar Neil

Chief Executive Officer · Director · BridgeBio Pharma, Inc.

BBIO

BridgeBio Pharma, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Indirect ownership · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. · Reported balance after transaction: 477186 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026. · Represents the weighted average sale price of the shares sold from $78.00 to $78.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. · The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

2026-11-192026-11-20

≈ $665,977.55

8,500 shares/units

SEC 4Follow
Kumar Neil

Chief Executive Officer · Director · BridgeBio Pharma, Inc.

BBIO

BridgeBio Pharma, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Indirect ownership · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. · Reported balance after transaction: 485686 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026. · Represents the weighted average sale price of the shares sold from $77.43 to $78.23 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. · The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

2026-11-182026-11-20

≈ $678,884.05

8,723 shares/units

SEC 4Follow
Kumar Neil

Chief Executive Officer · Director · BridgeBio Pharma, Inc.

BBIO

BridgeBio Pharma, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Indirect ownership · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. · Reported balance after transaction: 494409 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026. · Represents the weighted average sale price of the shares sold from $76.43 to $77.42 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. · The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

2026-11-182026-11-20

≈ $98,318.15

1,277 shares/units

SEC 4Follow
Kumar Neil

Chief Executive Officer · Director · BridgeBio Pharma, Inc.

BBIO

BridgeBio Pharma, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 243327 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026. · Represents the weighted average sale price of the shares sold from $77.43 to $78.23 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

2026-11-182026-11-20

≈ $2,372,948.28

30,490 shares/units

SEC 4Follow
Kumar Neil

Chief Executive Officer · Director · BridgeBio Pharma, Inc.

BBIO

BridgeBio Pharma, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 273817 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026. · Represents the weighted average sale price of the shares sold from $76.43 to $77.42 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

2026-11-182026-11-20

≈ $345,692.28

4,490 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 0 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

2026-11-192026-11-20

45,700 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 0 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

2026-11-192026-11-20

55,400 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 41895 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 2,262 shares sold at prices ranging from $147.38 to $148.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

2026-11-192026-11-20

≈ $333,645.00

2,262 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 44157 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 8,539 shares sold at prices ranging from $146.10 to $147.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

2026-11-192026-11-20

≈ $1,253,183.64

8,539 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 52696 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 90,299 shares sold at prices ranging from $145.00 to $145.93 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

2026-11-192026-11-20

≈ $13,098,772.94

90,299 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Common Stock · Direct ownership · Reported balance after transaction: 142995 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

2026-11-192026-11-20

45,700 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Common Stock · Direct ownership · Reported balance after transaction: 97295 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

2026-11-192026-11-20

55,400 shares/units

SEC 4Follow
Baes Nicholas

Chief Operating Officer · Bakkt, Inc.

BKKT

Bakkt, Inc.

Sell
Filing details

SEC transaction code S

Class A Common Stock · Direct ownership · Reported balance after transaction: 127114 · SEC code covers open-market or private transactions · The sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2026. · Represents a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.64 to $2.84, inclusive. · Includes 74,330 shares of Class A Common Stock subject to restricted stock units that remain subject to vesting.

2026-11-182026-11-20

≈ $19,219.75

6,989 shares/units

SEC 4Follow
Veinstein Bar

President, A&G · CLARIVATE PLC

CLVT

CLARIVATE PLC

Sell
Filing details

SEC transaction code S

Ordinary Shares · Direct ownership · Reported balance after transaction: 1008458 · SEC code covers open-market or private transactions · The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2026. · The price reported is a weighted average price. The prices ranged from $2.07 to $2.18, inclusive. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

2026-11-182026-11-20

≈ $542,208.54

254,558 shares/units

SEC 4Follow
Froetscher Janet P

Director · Cboe Global Markets, Inc.

CBOE

Cboe Global Markets, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 11422 · SEC code covers open-market or private transactions · The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2026.

2026-11-182026-11-20

≈ $525,681.92

1,448 shares/units

SEC 4Follow
Harper Gordon

CFO · Armour Residential REIT, Inc.

ARR

Armour Residential REIT, Inc.

Buy
Filing details

SEC transaction code P

Common Stock, par value $0.001 per share · Direct ownership · Reported balance after transaction: 36772 · SEC code covers open-market or private transactions

2026-11-202026-11-20

≈ $27,247.25

2,500 shares/units

SEC 4Follow
THOMAS MICHAEL H

Director · Installed Building Products, Inc.

IBP

Installed Building Products, Inc.

Gift or transfer
Filing details

SEC transaction code G

Common Stock, $0.01 par value per share · Direct ownership · Reported balance after transaction: 7630 · Gift to a charitable organization.

2026-11-182026-11-20

1,000 shares/units

SEC 4Follow
THOMAS MICHAEL H

Director · Installed Building Products, Inc.

IBP

Installed Building Products, Inc.

Sell
Filing details

SEC transaction code S

Common Stock, $0.01 par value per share · Direct ownership · Reported balance after transaction: 8630 · SEC code covers open-market or private transactions

2026-11-182026-11-20

≈ $136,672.90

598 shares/units

SEC 4Follow

Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.

Advertisement